CPI-006 2 mg/kg + SOC
CPI-006-003
Phase 3 small_molecule terminated
Quick answer
CPI-006 2 mg/kg + SOC for Covid-19 is a Phase 3 program (small_molecule) at Corvus Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Corvus Pharmaceuticals
- Indication
- Covid-19
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated